Rheopheresis in Patients with Ischemic Diabetic Foot Syndrome: Results of an Open Label Prospective Pilot Trial

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Therapeutic apheresis and dialysis

• Publication date

  2003-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1526-0968.2003.00082.xPMID 12887730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vital capillary microscopy for assessment of skin viability and microangiopathy in patients with diabetes mellitus.

  2009cited by this paper
• Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus.

  2002cited by this paper
• Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration

  2002cited by this paper
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

  2002cited by this paper
• Rheopheresis for age-related macular degeneration: a novel indication for therapeutic apheresis in ophthalmology.

  2002influential reference
• Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus.

  2002cited by this paper
• Hormones, metabolism and body composition as major determinants of blood rheology: Potential pathophysiological meaning

  2002cited by this paper
• Extracorporeal fibrinogen adsorption--efficacy, selectivity and safety in healthy subjects and patients with foot ulcers.

  2002cited by this paper
• Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up.

  2002cited by this paper
• High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.

  2001cited by this paper
• Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis.

  2001cited by this paper
• Improvement of macular function by membrane differential filtration in diabetic retinopathy

  2001cited by this paper
• Tissue Oxygenation and Skin Blood Flow in the Diabetic Foot: Responses to Cutaneous Warming

  2001cited by this paper
• What is high‐sensitivity C‐reactive protein?

  2001cited by this paper
• Early detection of microcirculatory impairment in diabetic patients with foot at risk.

  2001influential reference
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• The role of microcirculatory techniques in patients with diabetic foot syndrome.

  2000cited by this paper
• INFLUENCE OF MEMBRANE DIFFERENTIAL FILTRATION ON THE NATURAL COURSE OF AGE‐RELATED MACULAR DEGENERATION: A Randomized Trial

  2000cited by this paper
• The diabetic foot in the dialyzed patient.

  2000cited by this paper
• Hyperbaric oxygen therapy and the diabetic foot

  2000cited by this paper
• Rheopheresis: rheologic, functional, and structural aspects.

  2000cited by this paper
• Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial.

  2000influential reference
• Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.

  1998cited by this paper
• von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity.

  1998cited by this paper
• Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation

  1998cited by this paper
• Increased Mortality Associated with Diabetic Foot Ulcer

  1996cited by this paper
• Functional microcirculatory impairment: a possible source of reduced skin oxygen tension in human diabetes mellitus.

  1996cited by this paper
• TcPO2 as an accurate predictor of therapy in limb salvage

  1996cited by this paper
• A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems.

  1995cited by this paper
• Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes

  1992cited by this paper
• Chronology and Determinants of Tissue Repair in Diabetic Lower-Extremity Ulcers

  1991cited by this paper
• Plasma free N‐terminal fibronectin 30‐kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitus

  1990cited by this paper
• Transcutaneous oxygen pressure and hemorheology in diabetes mellitus.

  1990cited by this paper
• Evaluation of Skin Blood Flow and Venoarteriolar Response in Patients with Diabetes and Peripheral Vascular Disease by Laser Doppler Flowmetry

  1989cited by this paper
• Nomograms for the prediction of patient's plasma volume in plasma exchange therapy from height, weight, and hematocrit

  1987cited by this paper
• Plasma fibronectin as an indicator of microvascular damage in diabetic patients. Rapid and sensitive evaluation by a radial immunodiffusion technique

  1987cited by this paper
• The value of laser Doppler velocimetry and transcutaneous oxygen tension determination in predicting healing of ischemic forefoot ulcerations and amputations in diabetic and nondiabetic patients.

  1986cited by this paper
• Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease

  1985cited by this paper
• The Dysvascular Foot: A System for Diagnosis and Treatment

  1981cited by this paper
• The Dysvascular Foot: A System for Diagnosis and Treatment:

  1981cited by this paper
• Cutaneous and transcutaneous PO2 and PCO2 and their measuring conditions.

  1979cited by this paper
• Cutaneous and transcutaneous PO2 and PCO2 and their measuring conditions.

  1979cited by this paper

• Effects of Rheopheresis in dialysis patients with peripheral artery disease and diabetic foot ulcers: A multicentric Italian study

  2024influential citation
• [Uremic calciphylaxis].

  2022cites this paper
• Study Protocol: A Randomized Controlled Prospective Single-Center Feasibility Study of Rheopheresis for Raynaud’s Syndrome and Digital Ulcers in Systemic Sclerosis (RHEACT Study)

  2022cites this paper
• Rheopheresis: A narrative review

  2022cites this paper
• The effect of rheopheresis treatment on the cytokine profile in diabetic foot syndrome with hyperviscosity in the aspect of clinical changes: A preliminary study

  2021cites this paper
• A rheopheresiskezeléssel szerzett első hazai tapasztalatok.

  2021cites this paper
• [Iatrogenic non uremic calciphylaxis: A case report].

  2020cites this paper
• Optical coherence tomography: a novel imaging approach to visualize and quantify cutaneous microvascular structure and function in patients with diabetes

  2020cites this paper
• Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments

  2019cites this paper
• Pleiotropic Effect of Lipoprotein-Apheresis on the Soluble Form of Activated Leukocyte Cell Adhesion Molecule (sALCAM) in Familial Hypercholesterolaemia

  2018cites this paper
• How to examine and support microcirculation in pactients with diabetic foot

  2018cites this paper
• How to examine and support microcirculation in pactients with diabetic foot

  2018cites this paper
• Granulocyte/Monocyte Adsorption Apheresis as a Novel Therapeutic Approach in the Treatment of an Impetigo Herpetiformis Case

  2018cites this paper
• Rheopheresis for Adjuvant Treatment in Resistant Calciphylaxis

  2018cites this paper
• Therapeutic Apheresis in Metabolic Syndrome

  2018cites this paper
• The Difference Between the Healing and the Nonhealing Diabetic Foot Ulcer: A Review of the Role of the Microcirculation

  2017influential citation
• CARDIO-VASCULAR COMPLICATIONS IN PATIENTS WITH DIABETIC FOOT SYNDROME

  2016influential citation
• Hemorheological Failure in the Pathology of Cardio-vascular Complications in Patients with Diabetic Foot Syndrome

  2016cites this paper
• Double Filtration Plasmapheresis in Different Diseases in Thailand

  2013cites this paper
• Ldl Apheresis in peripheral arterial disease

  2013cites this paper
• Using rheopheresis for stem cell transplantation-associated thrombotic microangiopathy (TA-TMA).

  2013cites this paper
• The importance of rheological parameters in the therapy of the dry form of age-related macular degeneration with rheohaemapheresis

  2012cites this paper
• A Critical Review on the Use of Lipid Apheresis and Rheopheresis for Treatment of Peripheral Arterial Disease and the Diabetic Foot Syndrome

  2012influential citation
• Rheohemapheresis may be successful.

  2010cites this paper
• Diabetic retinopathy: Early diagnosis and effective treatment.

  2010cites this paper
• RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age‐Related Macular Degeneration

  2010cites this paper
• [Rheopheresis for recurrent sudden hearing loss : therapeutic options for patients refractory to infusion therapy].

  2010cites this paper
• Rheopherese bei rezidivierendem Hörsturz

  2010cites this paper
• Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration

  2009cites this paper
• Rheopheresis for sudden sensorineural hearing loss.

  2009cites this paper
• Acute and Subacute Effect of Rheopheresis on Microvascular Endothelial Function in Patients Suffering From Age‐related Macular Degeneration

  2009cites this paper
• The importance of rheological parameters in the therapy of microcirculatory disorders

  2009cites this paper
• [Rheopheresis for age-related macular degeneration].

  2009cites this paper
• Rheopherese® bei altersbedingter Makuladegeneration

  2009cites this paper
• Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial

  2009influential citation
• Lipid apheresis and rheopheresis for treatment of peripheral arterial disease.

  2009influential citation
• Quality of Life in Patients With Idiopathic Sudden Hearing Loss: Comparison of Different Therapies Using the Medical Outcome Short Form (36) Health Survey Questionnaire

  2008cites this paper
• Assessment of Lower Limb Ischemia With Measurement of Skin Perfusion Pressure in Patients on Hemodialysis

  2007cites this paper
• Gesicherte Indikationen zur Plasmapherese-Therapie bei internistischen und neurologischen Notfällen

  2006cites this paper
• Clinical outcomes and mechanism of action for rheopheresis treatment of age‐related macular degeneration (AMD)

  2005cites this paper
• Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action.

  2005cites this paper
• Acute Effect of Rheopheresis on Peripheral Endothelial Dysfunction in Patients Suffering From Sudden Hearing Loss

  2005cites this paper
• Rheopheresis in Patients with Critical Limb Ischemia––Results of an Open Label Prospective Pilot Trial

  2005influential citation
• Interim analysis of the MIRA-1 — multicenter double masked placebo controlled trial of rheopheresis in dry age-related macular degeneration (AMD) with soft drusen

  2004cites this paper